Envestnet Asset Management’s NRC Health Common Stock NRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $799K | Buy |
47,083
+16,752
| +55% | +$285K | ﹤0.01% | 3608 |
|
|
2025
Q4 | $569K | Sell |
30,331
-31,625
| -51% | -$477K | ﹤0.01% | 3616 |
|
|
2025
Q3 | $792K | Sell |
61,956
-14,594
| -19% | -$219K | ﹤0.01% | 3464 |
|
|
2025
Q2 | $1.29M | Sell |
76,550
-13,435
| -15% | -$182K | ﹤0.01% | 3116 |
|
|
2025
Q1 | $1.15M | Buy |
89,985
+16,868
| +23% | +$271K | ﹤0.01% | 3113 |
|
|
2024
Q4 | $1.29M | Sell |
73,117
-15,677
| -18% | -$297K | ﹤0.01% | 2987 |
|
|
2024
Q3 | $2.03M | Sell |
88,794
-4,811
| -5% | -$109K | ﹤0.01% | 2643 |
|
|
2024
Q2 | $2.15M | Sell |
93,605
-873
| -0.9% | -$26.9K | ﹤0.01% | 2559 |
|
|
2024
Q1 | $3.74M | Buy |
94,478
+74,162
| +365% | +$2.93M | ﹤0.01% | 2183 |
|
|
2023
Q4 | $804K | Sell |
20,316
-995
| -5% | -$41.7K | ﹤0.01% | 3066 |
|
|
2023
Q3 | $946K | Buy |
21,311
+8,853
| +71% | +$386K | ﹤0.01% | 2848 |
|
|
2023
Q2 | $542K | Buy |
12,458
+604
| +5% | +$26.6K | ﹤0.01% | 3157 |
|
|
2023
Q1 | $516K | Buy |
11,854
+715
| +6% | +$31.6K | ﹤0.01% | 3123 |
|
|
2022
Q4 | $415K | Buy |
11,139
+2,022
| +22% | +$78.2K | ﹤0.01% | 3201 |
|
|
2022
Q3 | $363K | Sell |
9,117
-79
| -0.9% | -$2.92K | ﹤0.01% | 3232 |
|
|
2022
Q2 | $352K | Buy |
9,196
+1,035
| +13% | +$37.4K | ﹤0.01% | 3267 |
|
|
2022
Q1 | $324K | Buy |
8,161
+599
| +8% | +$23.4K | ﹤0.01% | 3408 |
|
|
2021
Q4 | $314K | Buy |
7,562
+1,353
| +22% | +$58.8K | ﹤0.01% | 3388 |
|
|
2021
Q3 | $262K | Buy |
6,209
+1,028
| +20% | +$51.8K | ﹤0.01% | 3365 |
|
|
2021
Q2 | $238K | Sell |
5,181
-4,339
| -46% | -$206K | ﹤0.01% | 3415 |
|
|
2021
Q1 | $446K | Buy |
9,520
+2,762
| +41% | +$134K | ﹤0.01% | 2914 |
|
|
2020
Q4 | $289K | Sell |
6,758
-658
| -9% | -$33.8K | ﹤0.01% | 2942 |
|
|
2020
Q3 | $365K | Buy |
7,416
+340
| +5% | +$18.8K | ﹤0.01% | 2642 |
|
|
2020
Q2 | $412K | Buy |
+7,076
| New | +$374K | ﹤0.01% | 2519 |
|
|
2018
Q3 | – | Sell |
-2,543
| Closed | -$95K | – | 2138 |
|
|
2018
Q2 | $95K | Buy |
2,543
+247
| +11% | +$8.61K | ﹤0.01% | 1997 |
|
|
2018
Q1 | $67K | Buy |
2,296
+188
| +9% | +$6.31K | ﹤0.01% | 2048 |
|
|
2017
Q4 | $79K | Sell |
2,108
-187
| -8% | -$6.64K | ﹤0.01% | 2175 |
|
|
2017
Q3 | $87K | Buy |
2,295
+249
| +12% | +$7.82K | ﹤0.01% | 2118 |
|
|
2017
Q2 | $55K | Buy |
2,046
+40
| +2% | +$978 | ﹤0.01% | 2325 |
|
|
2017
Q1 | $39K | Buy |
2,006
+328
| +20% | +$6.07K | ﹤0.01% | 2496 |
|
|
2016
Q4 | $32K | Buy |
1,678
+139
| +9% | +$2.29K | ﹤0.01% | 2560 |
|
|
2016
Q3 | $25K | Buy |
1,539
+306
| +25% | +$4.8K | ﹤0.01% | 2776 |
|
|
2016
Q2 | $17K | Sell |
1,233
-2,100
| -63% | -$29.6K | ﹤0.01% | 2983 |
|
|
2016
Q1 | $52K | Buy |
3,333
+307
| +10% | +$4.5K | ﹤0.01% | 2705 |
|
|
2015
Q4 | $49K | Buy |
3,026
+1,048
| +53% | +$15.9K | ﹤0.01% | 2684 |
|
|
2015
Q3 | $24K | Buy |
+1,978
| New | +$26.3K | ﹤0.01% | 2884 |
|
|
2013
Q3 | – | Sell |
-2,128
| Closed | -$43K | – | 2457 |
|
|
2013
Q2 | $43K | Buy |
+2,128
| New | +$34K | ﹤0.01% | 1205 |
|
Other funds holding NRC
VCM
QI
Envestnet Asset Management's NRC Position: Q1 2026 in Review
Envestnet Asset Management increased its NRC Health Common Stock (NRC) stake by 55% in Q1 2026, buying an estimated $285K and bringing the position to 47,083 shares worth $799K. The position accounts for ﹤0.01% of the portfolio, ranked #3608.
Envestnet Asset Management first reported a position in NRC in Q2 2013 and has held it in 37 quarters since. The position peaked at $3.74M in Q1 2024. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.
- Envestnet Asset Management held 47,083 shares of NRC Health Common Stock worth $799K as of Q1 2026.
- Envestnet Asset Management bought 16,752 NRC Health Common Stock shares in Q1 2026, an estimated $285K.
- NRC Health Common Stock made up ﹤0.01% of Envestnet Asset Management's portfolio in Q1 2026, its #3608 holding.
- Envestnet Asset Management first reported a position in NRC Health Common Stock in Q2 2013 and has held it in 37 quarters since.
- Envestnet Asset Management's NRC Health Common Stock position peaked at $3.74M in Q1 2024.
- 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.
Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.